Hereditary Cancer

Cancer Wellness Panel

Beyond environment and lifestyle, inherited factors play an important role in cancer. This panel assesses hereditary breast, ovarian, pancreatic and prostate cancer, male breast cancer, primary peritoneal and fallopian tube cancer, Li-Fraumeni syndrome and other hereditary tumour risks, so screening and prevention can be planned around your own genetics.

Cancer Wellness Panel
Diseases Covered · 9 items (men) / 10 items (women)Report turnaround · 20 business days

DETECTION ITEMS

Diseases Covered

Hereditary Breast Cancer

Women only

Hereditary Breast Cancer

BRCA1 carriers face a lifetime risk of about 60-80% and BRCA2 carriers 40-70%, far above the 12% general population risk, with markedly earlier onset.

Ovarian Cancer

Women only

Ovarian Cancer

Known as the "silent killer" because early disease has almost no symptoms; lifetime risk is about 40-60% for BRCA1 carriers and 15-25% for BRCA2.

Fallopian Tube Cancer

Women only

Fallopian Tube Cancer

Many BRCA-related tumours once diagnosed as ovarian cancer in fact begin at the fallopian tube fimbriae, so the two are managed as one disease spectrum.

Primary Peritoneal Carcinoma

Primary Peritoneal Carcinoma

Arises on the peritoneal surface but is pathologically identical to BRCA-related ovarian cancer; a 1-4% lifetime risk remains even after risk-reducing salpingo-oophorectomy.

Male Breast Cancer

Men only

Male Breast Cancer

Rare, but BRCA2 raises a man's lifetime risk to 5-10% — roughly 80-100 times the general male risk — and low awareness often delays diagnosis.

Prostate Cancer

Men only

Prostate Cancer

BRCA2 carriers have a lifetime risk of about 20-30%, and their tumours are more aggressive and more likely to metastasise, so earlier PSA screening is advised.

Pancreatic Cancer

Pancreatic Cancer

BRCA2 carriers have a lifetime risk of about 3-7%, several times that of the general population. Early disease is almost symptomless and over 80% of cases are advanced at diagnosis.

Li-Fraumeni Syndrome

Li-Fraumeni Syndrome

A high-penetrance hereditary cancer syndrome caused by germline TP53 variants, with cumulative lifetime cancer risk up to 90% in women and 73% in men, very early onset and multiple primary tumours.

Osteosarcoma

Osteosarcoma

The most common malignant bone tumour in Li-Fraumeni syndrome, typically around the knee, presenting as bone pain that is worse at night plus local swelling.

Soft Tissue Sarcoma

Soft Tissue Sarcoma

Includes rhabdomyosarcoma and malignant peripheral nerve sheath tumour among other subtypes; one of the most common LFS tumours, usually a rapidly growing painless lump.

Adrenocortical Carcinoma

Adrenocortical Carcinoma

Li-Fraumeni syndrome accounts for 50-80% of childhood adrenocortical carcinoma. The tumour may oversecrete steroid hormones, producing Cushing's syndrome or virilisation.

Brain Tumors

Brain Tumors

LFS-related brain tumours are mainly astrocytoma and choroid plexus tumour, with earlier onset and high sensitivity to radiotherapy.

PROCESS

Testing Process

Four simple steps to complete professional genetic testing

1

Book Consultation

Assessment and consultation with medical professionals

2

Sample Collection

Simple oral mucosa sampling

3

Laboratory Testing

Professional gene sequence analysis

4

Report Interpretation

Detailed explanation by medical professionals

More Information

Contact us for full details of the Cancer Wellness Panel and the testing process

Contact Us
辰熙醫事檢驗所

Sunrise Medical Laboratory

A professional medical testing institution offering genetic testing, cancer screening, and various examination services to safeguard your health.

Contact Us

Business Hours

週一至週五:09:00 - 17:00

週六/日:休息

© 2026 辰熙醫事檢驗所. All rights reserved.

Line